These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 7699678)

  • 1. Pharmacokinetics and renal function in patients with rheumatoid arthritis receiving a standard dose of oral weekly methotrexate: association with significant decreases in creatinine clearance and renal clearance of the drug after 6 months of therapy.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):38-40. PubMed ID: 7699678
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Examination of pharmacokinetic variables in a cohort of patients with rheumatoid arthritis beginning therapy with methotrexate compared with a cohort receiving the drug for a mean of 81 months.
    Kremer JM; Petrillo GF; Hamilton RA
    J Rheumatol; 1995 Jan; 22(1):41-4. PubMed ID: 7699679
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The effects of nonsteroidal antiinflammatory drugs on methotrexate (MTX) pharmacokinetics: impairment of renal clearance of MTX at weekly maintenance doses but not at 7.5 mg.
    Kremer JM; Hamilton RA
    J Rheumatol; 1995 Nov; 22(11):2072-7. PubMed ID: 8596147
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The effects of food on methotrexate absorption.
    Hamilton RA; Kremer JM
    J Rheumatol; 1995 Apr; 22(4):630-2. PubMed ID: 7791153
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Methotrexate kinetics in rheumatoid arthritis: is there an interaction with nonsteroidal antiinflammatory drugs?
    Ahern M; Booth J; Loxton A; McCarthy P; Meffin P; Kevat S
    J Rheumatol; 1988 Sep; 15(9):1356-60. PubMed ID: 3199396
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lack of correlation between pharmacokinetics and efficacy of low dose methotrexate in patients with rheumatoid arthritis.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1995 May; 22(5):844-9. PubMed ID: 8587070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Combination therapy with methotrexate and hydroxychloroquine for rheumatoid arthritis increases exposure to methotrexate.
    Carmichael SJ; Beal J; Day RO; Tett SE
    J Rheumatol; 2002 Oct; 29(10):2077-83. PubMed ID: 12375315
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lack of interaction between bromfenac and methotrexate in patients with rheumatoid arthritis.
    Gumbhir-Shah K; Cevallos WH; DeCleene SA; Korth-Bradley JM
    J Rheumatol; 1996 Jun; 23(6):984-9. PubMed ID: 8782127
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined oral cyclosporin and methotrexate therapy in patients with rheumatoid arthritis elevates methotrexate levels and reduces 7-hydroxymethotrexate levels when compared with methotrexate alone.
    Fox RI; Morgan SL; Smith HT; Robbins BA; Choc MG; Baggott JE
    Rheumatology (Oxford); 2003 Aug; 42(8):989-94. PubMed ID: 12730515
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A pilot study of pharmacokinetically guided dosing of oral methotrexate in the initial phase of psoriasis treatment.
    Hroch M; Chladek J; Simkova M; Vaneckova J; Grim J; Martinkova J
    J Eur Acad Dermatol Venereol; 2008 Jan; 22(1):19-24. PubMed ID: 18031504
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Is there an interaction between low doses of corticosteroids and methotrexate in patients with rheumatoid arthritis? A pharmacokinetic study in 33 patients.
    Lafforgue P; Monjanel-Mouterde S; Durand A; Catalin J; Acquaviva PC
    J Rheumatol; 1993 Feb; 20(2):263-7. PubMed ID: 8474062
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Splitting high-dose oral methotrexate improves bioavailability: a pharmacokinetic study in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2006 Mar; 33(3):481-5. PubMed ID: 16463431
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Determinants of red blood cell methotrexate polyglutamate concentrations in rheumatoid arthritis patients receiving long-term methotrexate treatment.
    Stamp LK; O'Donnell JL; Chapman PT; Zhang M; Frampton C; James J; Barclay ML
    Arthritis Rheum; 2009 Aug; 60(8):2248-56. PubMed ID: 19644853
    [TBL] [Abstract][Full Text] [Related]  

  • 14. High-dose methotrexate therapy of childhood acute lymphoblastic leukemia: lack of relation between serum methotrexate concentration and creatinine clearance.
    Joannon P; Oviedo I; Campbell M; Tordecilla J
    Pediatr Blood Cancer; 2004 Jul; 43(1):17-22. PubMed ID: 15170885
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Lack of significant interaction between low dose methotrexate and ibuprofen or flurbiprofen in patients with arthritis.
    Skeith KJ; Russell AS; Jamali F; Coates J; Friedman H
    J Rheumatol; 1990 Aug; 17(8):1008-10. PubMed ID: 2213774
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Patients with rheumatoid arthritis treated with methotrexate (MTX): concentrations of steady-state erythrocyte MTX correlate to plasma concentrations and clinical efficacy.
    Hornung N; Ellingsen T; Attermann J; Stengaard-Pedersen K; Poulsen JH
    J Rheumatol; 2008 Sep; 35(9):1709-15. PubMed ID: 18634162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Methotrexate-nonsteroidal antiinflammatory drug interaction in children with arthritis.
    Dupuis LL; Koren G; Shore A; Silverman ED; Laxer RM
    J Rheumatol; 1990 Nov; 17(11):1469-73. PubMed ID: 2273487
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Bioavailability of higher dose methotrexate comparing oral and subcutaneous administration in patients with rheumatoid arthritis.
    Hoekstra M; Haagsma C; Neef C; Proost J; Knuif A; van de Laar M
    J Rheumatol; 2004 Apr; 31(4):645-8. PubMed ID: 15088287
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Celecoxib, a specific COX-2 inhibitor, has no significant effect on methotrexate pharmacokinetics in patients with rheumatoid arthritis.
    Karim A; Tolbert DS; Hunt TL; Hubbard RC; Harper KM; Geis GS
    J Rheumatol; 1999 Dec; 26(12):2539-43. PubMed ID: 10606360
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Bayesian calculation of methotrexate clearance after low dose intramuscular administration in patients with rheumatoid arthritis.
    Monjanel-Mouterde S; Lafforgue P; Blanc A; Catalin J; Aquaviva PC; Durand A
    J Rheumatol; 1998 Jul; 25(7):1276-81. PubMed ID: 9676756
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.